Valley National Advisers Inc. Makes New $62,000 Investment in CRISPR Therapeutics AG (NASDAQ:CRSP)

Valley National Advisers Inc. purchased a new position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 1,000 shares of the company’s stock, valued at approximately $62,000. A number of other large investors have […]

Leave a Reply

Your email address will not be published.

Previous post Trump drops off top 500 billionaires list
Next post Valley National Advisers Inc. Has $70,000 Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)